These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 10483027
21. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Cairns AP, Crockard AD, McConnell JR, Courtney PA, Bell AL. Ann Rheum Dis; 2001 Oct; 60(10):950-5. PubMed ID: 11557652 [Abstract] [Full Text] [Related]
22. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis. Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, Hilbrands LB, van der Vlag J. Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137 [Abstract] [Full Text] [Related]
23. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Funauchi M, Sugiyama M, SukYoo B, Ikoma S, Ohno M, Kinoshita K, Kanamaru A. Lupus; 2001 Feb; 10(4):284-8. PubMed ID: 11341105 [Abstract] [Full Text] [Related]
24. Circulating microparticles in systemic Lupus Erythematosus. Nielsen CT. Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755 [Abstract] [Full Text] [Related]
25. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus. Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T. Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093 [Abstract] [Full Text] [Related]
26. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujisaku A, Koike T. Clin Exp Immunol; 1995 Feb; 99(2):245-50. PubMed ID: 7531628 [Abstract] [Full Text] [Related]
27. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus. Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C. Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229 [Abstract] [Full Text] [Related]
28. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR. Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943 [Abstract] [Full Text] [Related]
30. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients]. Chen X, Wang LL, Cai B, Chen J, Feng WH. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902 [Abstract] [Full Text] [Related]
31. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [Abstract] [Full Text] [Related]
32. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H. Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733 [Abstract] [Full Text] [Related]
33. Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE. Kovacs B, Szentendrei T, Bednarek JM, Pierson MC, Mountz JD, Vogelgesang SA, Tsokos GC. Clin Exp Rheumatol; 1997 May; 15(1):19-23. PubMed ID: 9093768 [Abstract] [Full Text] [Related]
34. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL, Mason JC, Davies KA. Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [Abstract] [Full Text] [Related]
35. Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Gröndal G, Traustadottir KH, Kristjansdottir H, Lundberg I, Klareskog L, Erlendsson K, Steinsson K. Lupus; 2002 May; 11(7):435-42. PubMed ID: 12195785 [Abstract] [Full Text] [Related]
36. Increased expression of CD154 and FAS in SLE patients' lymphocytes. Manea ME, Mueller RB, Dejica D, Sheriff A, Schett G, Herrmann M, Kern P. Rheumatol Int; 2009 Dec; 30(2):181-5. PubMed ID: 19404646 [Abstract] [Full Text] [Related]
37. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese. Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ. Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345 [Abstract] [Full Text] [Related]
38. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. Lee YH, Kim YR, Ji JD, Sohn J, Song GG. J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967 [Abstract] [Full Text] [Related]
39. Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes. Eggleton P, Harries LW, Alberigo G, Wordsworth P, Viner N, Haigh R, Donnelly S, Jones HW, Chikanza IC, O'Conner TW, Thomson AE, Winyard PG. J Clin Immunol; 2010 Sep; 30(5):649-58. PubMed ID: 20532967 [Abstract] [Full Text] [Related]
40. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. Emlen W, Niebur J, Kadera R. J Immunol; 1994 Apr 01; 152(7):3685-92. PubMed ID: 8144943 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]